Genomica, a Spanish company specializing in molecular diagnosis, has been exploded by the coronavirus epidemic at its best. Two years ago he opened an office in Wuhan, the city that today is the epicenter of the latest global health threat. He established warehouses in the city and began to create networks of collaboration with local companies. Now this subsidiary of PharmaMar is the best placed company to supply rapid diagnostic kits for the new pathogen and competes with other international companies.
If the deadlines are met as planned, Genomica hopes to obtain an accelerated approval from the Agency for Medicines and Health Products to present the new tests in the second week of March. ...